CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 250 of 434 entries

View as:

A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

Phase: N/A Priority: Normal

NCT ID: NCT00156078 Org: User:

Start: 01/31/05 End: 05/31/07 Due: 05/31/08

A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form

Phase: N/A Priority: Normal

NCT ID: NCT04391868 Org: User:

Start: 01/30/21 End: 04/28/21 Due: 04/28/22

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00596466 Org: User:

Start: 04/30/08 End: 12/31/11 Due: 12/31/12

Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil

Phase: N/A Priority: Normal

NCT ID: NCT01737203 Org: User:

Start: 08/31/12 End: 09/30/12 Due: 09/30/13

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Phase: N/A Priority: Normal

NCT ID: NCT00265330 Org: User:

Start: 03/31/06 End: 01/31/08 Due: 01/31/09

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal

NCT ID: NCT01107743 Org: User:

Start: 06/30/10 End: 04/30/12 Due: 04/30/13

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder

Phase: N/A Priority: Normal

NCT ID: NCT01302938 Org: User:

Start: 03/31/11 End: 08/31/12 Due: 08/31/13

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT00136942 Org: User:

Start: 04/30/05 End: - Due: -

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

Phase: N/A Priority: Normal

NCT ID: NCT01190007 Org: User:

Start: 08/31/10 End: 02/29/12 Due: 02/28/13

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

Phase: N/A Priority: Normal

NCT ID: NCT01049217 Org: User:

Start: 04/30/10 End: 05/31/12 Due: 05/31/13

Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01699724 Org: User:

Start: 09/30/12 End: 10/31/12 Due: 10/31/13

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

Phase: N/A Priority: Normal

NCT ID: NCT00143234 Org: User:

Start: 05/31/04 End: 07/31/05 Due: 07/31/06

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines

Phase: N/A Priority: Normal

NCT ID: NCT00232180 Org: User:

Start: 03/31/06 End: 01/31/12 Due: 01/31/13

Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

Phase: N/A Priority: Normal

NCT ID: NCT01150903 Org: User:

Start: 05/31/10 End: 08/31/10 Due: 08/31/11

Food Effect Study For New Formulation

Phase: N/A Priority: Normal

NCT ID: NCT01656798 Org: User:

Start: 08/31/12 End: 08/31/12 Due: 08/31/13

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Phase: N/A Priority: Normal

NCT ID: NCT01285505 Org: User:

Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT00830167 Org: User:

Start: 03/31/09 End: 05/31/11 Due: 05/31/12

A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.

Phase: N/A Priority: Normal

NCT ID: NCT00716859 Org: User:

Start: 07/31/08 End: 11/30/09 Due: 11/30/10

A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

Phase: N/A Priority: Normal

NCT ID: NCT00645034 Org: User:

Start: 11/30/02 End: 07/31/03 Due: 07/31/04

Pregabalin In Adolescent Patients With Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT01020526 Org: User:

Start: 09/30/10 End: 06/30/15 Due: 06/30/16

A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT00645151 Org: User:

Start: 04/30/04 End: 02/28/05 Due: 02/28/06

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Phase: N/A Priority: Normal

NCT ID: NCT00159770 Org: User:

Start: 11/30/01 End: 09/30/04 Due: 09/30/05

Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT00640549 Org: User:

Start: 03/31/03 End: 10/31/04 Due: 10/31/05

Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00640458 Org: User:

Start: 04/30/04 End: 03/31/07 Due: 03/31/08

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Phase: N/A Priority: Normal

NCT ID: NCT00585312 Org: User:

Start: 09/30/06 End: 10/31/13 Due: 10/31/14

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)	NCT00156078	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-01-31	2007-05-31	2008-05-31	-	-	2025-07-14
A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form	NCT04391868	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2021-01-30	2021-04-28	2022-04-28	-	-	2025-07-14
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures	NCT00596466	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-04-30	2011-12-31	2012-12-31	-	-	2025-07-14
Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil	NCT01737203	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-08-31	2012-09-30	2013-09-30	-	-	2025-07-14
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)	NCT00265330	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-03-31	2008-01-31	2009-01-31	-	-	2025-07-14
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)	NCT01107743	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-06-30	2012-04-30	2013-04-30	-	-	2025-07-14
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder	NCT01302938	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-03-31	2012-08-31	2013-08-31	-	-	2025-07-14
A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol	NCT00136942	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-04-30	-	-	-	-	2025-07-14
Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients	NCT01190007	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-08-31	2012-02-29	2013-02-28	-	-	2025-07-14
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy	NCT01049217	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-04-30	2012-05-31	2013-05-31	-	-	2025-07-14
Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects	NCT01699724	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-09-30	2012-10-31	2013-10-31	-	-	2025-07-14
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels	NCT00143234	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-05-31	2005-07-31	2006-07-31	-	-	2025-07-14
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines	NCT00232180	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-03-31	2012-01-31	2013-01-31	-	-	2025-07-14
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor	NCT01150903	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-05-31	2010-08-31	2011-08-31	-	-	2025-07-14
Food Effect Study For New Formulation	NCT01656798	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-08-31	2012-08-31	2013-08-31	-	-	2025-07-14
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation	NCT01285505	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-04-30	2011-06-30	2012-06-30	-	-	2025-07-14
Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia	NCT00830167	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-03-31	2011-05-31	2012-05-31	-	-	2025-07-14
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.	NCT00716859	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-07-31	2009-11-30	2010-11-30	-	-	2025-07-14
A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin	NCT00645034	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-11-30	2003-07-31	2004-07-31	-	-	2025-07-14
Pregabalin In Adolescent Patients With Fibromyalgia	NCT01020526	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-09-30	2015-06-30	2016-06-30	-	-	2025-07-14
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol	NCT00645151	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-04-30	2005-02-28	2006-02-28	-	-	2025-07-14
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients	NCT00159770	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2001-11-30	2004-09-30	2005-09-30	-	-	2025-07-14
Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus	NCT00640549	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-03-31	2004-10-31	2005-10-31	-	-	2025-07-14
Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder	NCT00640458	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-04-30	2007-03-31	2008-03-31	-	-	2025-07-14
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)	NCT00585312	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-09-30	2013-10-31	2014-10-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance